Vertex Pharmaceuticals
Search results
mRNA medicines fight diseases in a different way than traditional medicine by prompting your immune system to create the tools to treat or prevent disease. We believe that if mRNA can treat one disease, it can treat many diseases. We will use mRNA to treat diseases for which there are currently no treatments.
- Our Story
We’re making biotech history. Messenger RNA is not new...
- Our Mission & Values
We are committed to creating an inclusive and diverse...
- Investor Relations Overview
Overview of Moderna news, events & presentations, latest...
- Moderna's mRNA Platform
The mRNA DESIGN STUDIO integrates with Moderna’s automation...
- Our Story
Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
- 200 Tech Square, Cambridge, 02139, MA
- drugsafety@modernatx.com
- 1800 622 4937
We’re making biotech history. Messenger RNA is not new technology, but we are discovering new ways to use it to treat and prevent illnesses and diseases. Since our founding in 2010, we have worked to build the industry's leading mRNA technology platform.
Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
Mar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
Feb 3, 2021 · The Moderna COVID-19 vaccine has been authorised for use in Singapore in individuals aged 18 years and above. The first shipment arrived in Singapore on 17 February 2021. Details of the Moderna COVID-19 vaccine. For individuals aged 18 years and above; Two doses required, administered 28 days apart; High vaccine efficacy of 94%
Aug 18, 2022 · The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
